Cargando…
Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis
BACKGROUND: Clopidogrel is a cornerstone antiplatelet drug used in cardiovascular, cerebrovascular, and peripheral artery diseases. The sulfhydryl group of clopidogrel metabolite could induce insulin autoimmune syndrome (IAS) with hypoglycemia as the major symptom. Discontinuing clopidogrel and subs...
Autores principales: | Chen, Shi, Qiang, Jiaqi, Zhang, Yuelun, Zhao, Bin, Tian, Ran, Yuan, Tao, Li, Ming, Li, Mei, Li, Yuxiu, Zhu, Huijuan, Pan, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011644/ https://www.ncbi.nlm.nih.gov/pubmed/36926026 http://dx.doi.org/10.3389/fendo.2023.1091933 |
Ejemplares similares
-
Clopidogrel as a Distinctive Cause of Insulin Autoimmune Syndrome: A Systematic Case Review
por: Chen, Shi, et al.
Publicado: (2023) -
The optimal diagnostic criteria of endogenous hyperinsulinemic hypoglycemia based on a large cohort of Chinese patients
por: Yu, Jie, et al.
Publicado: (2022) -
Interaction of PM(2.5) and pre-pregnancy body mass index on birth weight: A nationwide prospective cohort study
por: Du, Hanze, et al.
Publicado: (2022) -
Altered Serum Amino Acid and Acylcarnitine Profiles in Hyperinsulinemic Hypoglycemia and Ketotic Hypoglycemia
por: Xu, Zhen-Ran, et al.
Publicado: (2020) -
The Negative Impacts of Acromegaly on Bone Microstructure Not Fully Reversible
por: Duan, Lian, et al.
Publicado: (2021)